DEF14A PROXY STATEMENT

Company

Kura Oncology, Inc.

Filed

April 26, 2018

Period of Report

June 7, 2018

Accession Number

0001564590-18-009303

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →